-
NMPA held a working conference on the TCM quality and safety regulation
2021-12-31
On December 29, NMPA held a working conference on the TCM quality and safety regulation to comprehensively summarize relevant work in 2021, deeply analyze current regulatory situation and matters, and deploy the priorities in 2022 to continuously enhance the TCM quality and safety regulation.
-
Issuance of the 14th Five-Year Plan for National Drug Safety and High-Quality Development
2021-12-30
The Plan calls for strengthening the overall coordination and leadership of drug safety, innovating and improving the support and guarantee mechanism, actively participating in global drug safety governance, and encouraging drug regulators to fulfill their duties and responsibilities.
-
Chinese mainland reports 152 locally transmitted COVID-19 cases
2021-12-29
The Chinese mainland on Tuesday reported 152 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Dec 29.
-
2.78b COVID-19 vaccine doses administered on Chinese mainland
2021-12-29
More than 2.78 billion COVID-19 vaccine doses had been administered on the Chinese mainland as of Monday, data from the National Health Commission showed on Dec 28.
-
China releases development plan for medical equipment industry
2021-12-29
China unveiled a development plan for the medical equipment sector during the 14th Five-Year Plan period (2021-2025) on Dec 28, as part of efforts to bolster public health.
-
NMPA and Hainan Province Jointly Promoted the Pilot Application of Clinical Real-World Data of Drugs and Devices
2021-12-28
On December 28, 2021, the NMPA and the Hainan Province jointly convened the third meeting of the leading group on the pilot application of clinical real-world data of drugs and devices in 2021.
